Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ¿50 Years: Final 96-Week Results of the NEAT022 Study Academic Article 2019 uri icon

authors

  • Gatell JM
  • Guaraldi G
  • MASIA CANUTO, MARIA DEL MAR
  • Gompels M
  • De Wit S
  • Florence E
  • Esser S
  • Raffi F
  • Stephan C
  • Rockstroh J
  • Giacomelli A
  • Assoumou L
  • Vera J
  • Bernardino JI
  • Winston A
  • Saumoy M
  • Gras J
  • Katlama C
  • Pozniak AL
  • European Network for AIDS Treatment 022 (NEAT022) Study Group
  • Moyle G
  • Waters L
  • Johnson M
  • Domingo P
  • Fox J
  • Martinez E
  • BOIX MARTINEZ, VICENTE
  • Stellbrink H
  • GUTIERREZ RODERO, FELIX

publication date

  • 2019